Inventor · disambiguated record
Patrick Blanco
Also filed as: BLANCO PATRICK
6 granted patents·8 pending applications·18 citations·filing 2000–2023
75Inventor score
Files withINST NAT SANTE RECH MED5BAYLOR RES INST3UNIV BORDEAUX3BAYLOR RES INSTITUTE2BANCHEREAU JACQUES F1
Top patents by PatentIndex Score
14 records- 0177US7544357B2Methods for treating autoimmune diseases in a subject and in vitro diagnostic assaysBAYLOR RES INST·Filed 2002·Granted Jun 9, 2009·11 cites·6 claims
- 0266US7988963B1Use of allogeneic cell lines to load antigen presenting cells to elicit or eliminate immune responsesBAYLOR RES INST·Filed 2000·Granted Aug 2, 2011·6 cites·15 claims
- 0365US10167339B2Antagonistic anti-OX40L antibodies and methods of their useBAYLOR RES INSTITUTE·Filed 2015·Granted Jan 1, 2019·1 cites·16 claims
- 0458US2025002596A1Neutralizing anti-cd95l monoclonal antibodiesINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0557US2009263474A1Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic AssaysBANCHEREAU JACQUES F·Filed 2009·Application pending·0 cites
- 0655US2025163169A1Antibodies for preventing the cleavage of cd95l by metalloproteasesINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0752US10570208B2Antagonistic anti-OX40L antibodies and methods of their useBAYLOR RES INSTITUTE·Filed 2018·Granted Feb 25, 2020·0 cites·20 claims
- 0847US2011268767A1Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responsesBAYLOR RES INST·Filed 2011·Application pending·0 cites
- 0945US12186366B2Clusterin for use in the treatment of thrombotic microangiopathiesUNIV BORDEAUX·Filed 2018·Granted Jan 7, 2025·0 cites·7 claims
- 1045US2021115131A1Treatment of Placental Chronic Histiocytic Intervillositis Using an Inhibitor of Interleukin-1UNIV BORDEAUX·Filed 2019·Application pending·0 cites
- 1143US2019350907A1Methods and pharmaceutical compositions for reducing cd95- mediated cell motilityINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 1238US11905253B2Compounds and pharmaceutical compositions for reducing CD95-mediated cell motilityINST NAT SANTE RECH MED·Filed 2019·Granted Feb 20, 2024·0 cites·19 claims
- 1333US2018298104A1Methods and pharmaceutical compositions for the treatment of th17 mediated diseasesINST NAT SANTE RECH MED·Filed 2016·Application pending·0 cites
- 1430US2019015397A1Substance that inhibits p2y12 receptor, for use in the preventive treatment of systemic sclerosis in patients with raynaud's phenomenon and a dysimmunityUNIV BORDEAUX·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Blanco files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →